These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 29540148)

  • 1. A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone.
    Vazquez N; Sanchez L; Marks R; Martinez E; Fanniel V; Lopez A; Salinas A; Flores I; Hirschmann J; Gilkerson R; Schuenzel E; Dearth R; Halaby R; Innis-Whitehouse W; Keniry M
    BMC Mol Biol; 2018 Mar; 19(1):3. PubMed ID: 29540148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.
    Sahoo N; Cuello V; Udawant S; Litif C; Mustard JA; Keniry M
    Methods Mol Biol; 2020; 2115():365-383. PubMed ID: 32006411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines.
    Wardyn JD; Chan ASY; Jeyasekharan AD
    Curr Protoc; 2021 Nov; 1(11):e286. PubMed ID: 34748280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes.
    Li Z; Bi Y; Xiao H; Sun L; Ren Y; Li Y; Chen C; Cun W
    Virus Res; 2018 Jan; 244():286-295. PubMed ID: 28279800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing.
    Suresh B; Ramakrishna S; Kim H
    Methods Mol Biol; 2017; 1507():81-94. PubMed ID: 27832534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering Mutation Clones in Mammalian Cells with CRISPR/Cas9.
    Huo Z; Tu J; Lee DF; Zhao R
    Methods Mol Biol; 2020; 2108():355-369. PubMed ID: 31939194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple CRISPR-Cas9 Genome Editing in Saccharomyces cerevisiae.
    Laughery MF; Wyrick JJ
    Curr Protoc Mol Biol; 2019 Dec; 129(1):e110. PubMed ID: 31763795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and Stability of All-in-One Adenovirus Vectors Simultaneously Expressing Four and Eight Multiplex Guide RNAs and Cas9 Nickase.
    Nakahara T; Tabata H; Kato Y; Fuse R; Nakamura M; Yamaji M; Hattori N; Kiyono T; Saito I; Nakanishi T
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the CRISPR-Cas9 System in Drosophila Cultured Cells to Introduce Fluorescent Tags into Endogenous Genes.
    Bosch JA; Knight S; Kanca O; Zirin J; Yang-Zhou D; Hu Y; Rodiger J; Amador G; Bellen HJ; Perrimon N; Mohr SE
    Curr Protoc Mol Biol; 2020 Mar; 130(1):e112. PubMed ID: 31869524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 for Mutagenesis in Rice.
    Char SN; Li R; Yang B
    Methods Mol Biol; 2019; 1864():279-293. PubMed ID: 30415343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.
    Cullot G; Boutin J; Toutain J; Prat F; Pennamen P; Rooryck C; Teichmann M; Rousseau E; Lamrissi-Garcia I; Guyonnet-Duperat V; Bibeyran A; Lalanne M; Prouzet-Mauléon V; Turcq B; Ged C; Blouin JM; Richard E; Dabernat S; Moreau-Gaudry F; Bedel A
    Nat Commun; 2019 Mar; 10(1):1136. PubMed ID: 30850590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Versatile and precise gene-targeting strategies for functional studies in mammalian cell lines.
    Wassef M; Luscan A; Battistella A; Le Corre S; Li H; Wallace MR; Vidaud M; Margueron R
    Methods; 2017 May; 121-122():45-54. PubMed ID: 28499832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci.
    Najah S; Saulnier C; Pernodet JL; Bury-Moné S
    BMC Biotechnol; 2019 Mar; 19(1):18. PubMed ID: 30894153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introducing Point Mutations into Human Pluripotent Stem Cells using Seamless Genome Editing.
    Wang Y; Smith AJH; Hay DC
    J Vis Exp; 2020 May; (159):. PubMed ID: 32449724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.